New developments in hyperphosphatemia managementSLATOPOLSKY, Eduardo.Journal of the American Society of Nephrology. 2003, Vol 14, Num 9, issn 1046-6673, 25 p., SUP4Serial Issue

Impact of dyslipidemia in end-stage renal diseasePRICHARD, Sarah S.Journal of the American Society of Nephrology. 2003, Vol 14, Num 9, pp S315-S320, issn 1046-6673, SUP4Article

Vascular calcification: In vitro evidence for the role of inorganic phosphateGIACHELLI, Cecilia M.Journal of the American Society of Nephrology. 2003, Vol 14, Num 9, pp S300-S304, issn 1046-6673, SUP4Article

Slowing the progression of vascular calcification in hemodialysisCHERTOW, Glenn M.Journal of the American Society of Nephrology. 2003, Vol 14, Num 9, pp S310-S314, issn 1046-6673, SUP4Article

Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular functionLONDON, Gérard M.Journal of the American Society of Nephrology. 2003, Vol 14, Num 9, pp S305-S309, issn 1046-6673, SUP4Article

New vitamin D analogues in the treatment of secondary hyperparathyroidismLLACH, Francisco; SLATOPOLSKY, Eduardo.American journal of kidney diseases. 1998, Vol 32, Num 2, issn 0272-6386, 68 p., SUP2Serial Issue

Vitamin D analogues for secondary hyperparathyroidismBROWN, Alex J; DUSSO, Adriana S; SLATOPOLSKY, Eduardo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 10-19, issn 0931-0509, SUP10Conference Paper

Vitamin DDUSSO, Adriana S; BROWN, Alex J; SLATOPOLSKY, Eduardo et al.American journal of physiology. Renal physiology. 2005, Vol 58, Num 1, pp F8-F28, issn 1931-857XArticle

FGF23 and PTH—double agents at the heart of CKDSILVER, Justin; RODRIGUEZ, Mariano; SLATOPOLSKY, Eduardo et al.Nephrology, dialysis, transplantation (Print). 2012, Vol 27, Num 5, pp 1715-1720, issn 0931-0509, 6 p.Article

Differential effects of 19-nor-1,25-dihydroxyvitamin D₂ and 1,25-dihydroxyvitamin D₃ on intestinal calcium and phosphate transportBROWN, Alex J; FINCH, Jane; SLATOPOLSKY, Eduardo et al.The Journal of laboratory and clinical medicine. 2002, Vol 139, Num 5, pp 279-284, issn 0022-2143Article

Advances in Research on Vitamin D and Uraemic Bone Disease: 22-Oxacalcitriol as a New Drug for Secondary Hyperparathyroidism, Hawaii, USA, 14 December 2001FUKAGAWA, Masafumi; KUROKAWA, Kiyoshi; SLATOPOLSKY, Eduardo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, issn 0931-0509, 59 p., SUP10Conference Proceedings

Vascular Calcification: The Killer of Patients with Chronic Kidney DiseaseMIZOBUCHI, Masahide; TOWLER, Dwight; SLATOPOLSKY, Eduardo et al.Journal of the American Society of Nephrology. 2009, Vol 20, Num 7, pp 1453-1464, issn 1046-6673, 12 p.Article

Differential effects of 19-nor-1,25-(OH)₂D₂ and 1α-hydroxyvitamin D₂ on calcium and phosphorus in normal and uremic ratsSLATOPOLSKY, Eduardo; COZZOLINO, Mario; FINCH, Jane L et al.Kidney international. 2002, Vol 62, Num 4, pp 1277-1284, issn 0085-2538Article

Pathogenesis of vascular calcification in chronic kidney diseaseCOZZOLINO, Mario; BRANCACCIO, Diego; GALLIENI, Maurizio et al.Kidney international. 2005, Vol 68, Num 2, pp 429-436, issn 0085-2538, 8 p.Article

Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failureCOZZOLINO, Mario; DUSSO, Adriana S; SLATOPOLSKY, Eduardo et al.Journal of the American Society of Nephrology. 2001, Vol 12, Num 11, pp 2511-2516, issn 1046-6673Article

Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failureLLACH, F; YUDD, M.American journal of kidney diseases. 1998, Vol 32, Num 2, pp S3-S12, issn 0272-6386, SUP2Article

Vitamin D analoguesBROWN, A. J.American journal of kidney diseases. 1998, Vol 32, Num 2, pp S25-S39, issn 0272-6386, SUP2Article

Progressive accumulation of lanthanum in the liver of normal and uremic ratsSLATOPOLSKY, Eduardo; LIAPIS, Helen; FINCH, Jane et al.Kidney international. 2005, Vol 68, Num 6, pp 2809-2813, issn 0085-2538, 5 p.Article

Should vitamin D analogs be the therapy of preference for ESRD patients with secondary hyperparathyroidism ?SLATOPOLSKY, Eduardo; MARTIN, Kevin J; SHERRARD, Donald J et al.Dialysis & transplantation. 2001, Vol 30, Num 4, pp 190-195, issn 0090-2934, 5 p.Article

Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D₃ on secondary hyperparathyroidism in dogs with chronic renal failureTAKAHASHI, Fumiaki; FURUICHI, Tatsuya; YOROZU, Keigo et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 46-52, issn 0931-0509, SUP10Conference Paper

Parathyroid cells cultured in collagen matrix retain calcium responsiveness: Importance of three-dimensional tissue architectureRITTER, Cynthia S; SLATOPOLSKY, Eduardo; SANTORO, Samuel et al.Journal of bone and mineral research (Print). 2004, Vol 19, Num 3, pp 491-498, issn 0884-0431, 8 p.Article

Mechanism of vitamin D action and its regulationDUSSO, A. S; BROWN, A. J.American journal of kidney diseases. 1998, Vol 32, Num 2, pp S13-S24, issn 0272-6386, SUP2Article

Calcemic activity of 19-Nor-1,25(OH)₂D₂ decreases with duration of treatmentBROWN, Alex J; FINCH, Jane; TAKAHASHI, Fumiaki et al.Journal of the American Society of Nephrology. 2000, Vol 11, Num 11, pp 2088-2094, issn 1046-6673Article

Hyperplasia of the parathyroid gland without secondary hyperparathyroidismTAKAHASHI, Fumiaki; DENDA, Masashi; FINCH, Jane L et al.Kidney international. 2002, Vol 61, Num 4, pp 1332-1338, issn 0085-2538Article

Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptorRITTER, Cynthia S; FINCH, Jane L; SLATOPOLSKY, Eduardo A et al.Kidney international. 2001, Vol 60, Num 5, pp 1737-1744, issn 0085-2538Article